Open an account

Mangoceuticals

MGRX · NASDAQ

$0.30+$0.0199 (+7.10%)TodayMarket closed ·
Prev close $0.2801

About MGRX

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.

Employees
0
Headquarters
Dallas, Texas
Listed
Mar 21, 2023
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Website
mangorx.com

MGRX key statistics

Market cap
6.67M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
621.22K
Volume
178.27K
Open price
$0.29
High today
$0.305
Low today
$0.2801
52 Week high
$2.75
52 Week low
$0.162

Mangoceuticals (MGRX) at a glance

As of Oct 20, 2026, Mangoceuticals (MGRX) shares are priced at $0.30, giving the company a market cap of 6.67M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.2801 and $0.305. The current price is 7.1% above the day's low and 1.6% below its high.

Volume so far is 178.27K shares, below the average of 621.22K shares a day.

Over the past year Mangoceuticals has ranged from $0.162 to $2.75, and now sits 5% of the way up that range.

MGRX news

  • Rishabh Mishra

    Stock Market Today: S&P 500, Dow Jones Futures Gain as September Jobs Report Misses Expectations— Nike, Synaptics, Corteva in Focus (UPDATED)

  • Tanya Rawat

    Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why

  • 12 Consumer Staples Stocks Moving In Monday's After-Market Session

  • Press releaseBusiness Wire

    MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders

  • 12 Consumer Staples Stocks Moving In Thursday's After-Market Session

  • Press releaseNewsfile

    Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

  • Press releaseGlobe Newswire

    Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

  • Mohd Haider

    Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why

Similar companies

Companies in the same industry as Mangoceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.